COMMUNIQUÉS West-GlobeNewswire

Halo Pharma Enhances Manufacturing Capabilities with Macro-Pactor® Investment
16/12/2025
New addition enhances manufacturing continuity and supports seamless progression from early-phase development to late-stage production Macro-Pactor ® to be online in Q1 2026 WHIPPANY, N.J., Dec. 16, 2025 (GLOBE NEWSWIRE [...]
Weight Watchers lance une plateforme entièrement intégrée pour une nouvelle ère de santé liée au poids
16/12/2025
L’expérience Weight Watchers repensée combine nutrition personnalisée, contenus spécialisés, coaching et technologies de pointe pour aider les membres à atteindre leurs objectifs de perte de poids et obtenir des [...]
Sienna Completes Acquisition in Waterloo, Ontario
16/12/2025
This news release constitutes a “designated news release” for the purposes of Sienna’s amended and restated prospectus supplement dated November 14, 2025 to its short form base shelf prospectus dated November 29, 2024. [...]
YD Bio Limited Expands U.S. Presence with Newly Planned California Facilities and Operations Center
16/12/2025
Taipei, Taiwan, Dec. 16, 2025 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic [...]
J-Star Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
16/12/2025
TAICHUNG CITY, Taiwan, Dec. 16, 2025 (GLOBE NEWSWIRE) -- J-Star Holding Co., Ltd. (Nasdaq: YMAT) (“J-Star” or the “Company”), a leading provider of innovative carbon fiber and composite solutions across a wide range of [...]
Weight Watchers Launches a Fully Integrated Platform for the GLP-1 Era
16/12/2025
A redesigned Weight Watchers experience pairs GLP-1 prescriptions with personalized nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and achieve results [...]
Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan
16/12/2025
Vivos Eyes High Growth Potential from Commercial Affiliation with Prominent Auburn Hills, Michigan Sleep Practice MISleep Solutions LITTLETON, Colo., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” [...]
Clearmind Medicine Announces Successful Completion of Second Cohort Enrollment in Ongoing FDA-Approved Phase I/IIa Trial for CMND-100
16/12/2025
Vancouver, Canada, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel [...]
Silexion Therapeutics Announces Submission of Phase 2/3 Clinical Trial Application to Israel for SIL204 in Locally Advanced Pancreatic Cancer
16/12/2025
Regulatory submission marks a significant milestone as the Company advances toward Phase 2/3 trial initiation in Q2 2026 at full speed Application follows recent successful toxicology studies, positive German regulatory [...]
Zelluna Publishes Compelling Preclinical Data for ZI-MA4-1, the World's First MAGE-A4-Targeting TCR-NK Therapy for Solid Tumours
16/12/2025
Strong preclinical data support planned clinical trial initiation in 2026 Oslo, Norway, 16 December 2025– Zelluna (OSE: ZLNA), a company developing off-the-shelf cell therapies for cancer, today announced the [...]
Beacon Biosignals Announces Partnership with Harmony Biosciences to Advance Objective Clinical Endpoints in Hypersomnia Conditions Through Quantitative EEG
16/12/2025
BOSTON, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Beacon Biosignals, a leader in AI-driven neurophysiology and precision drug development, today announced a collaboration with Harmony Biosciences (Nasdaq: HRMY), a [...]
Culture Biosciences Announces Close of Series C Round to Accelerate Commercial Growth of Stratyx 250 and Console Platform
16/12/2025
New funding accelerates the expansion of the Stratyx™ platform, advancing automated, cloud-connected bioprocessing and AI-driven software capabilities SOUTH SAN FRANCISCO, CALIFORNIA, UNITED STATES, Dec. 16, 2025 (GLOBE [...]
VIRBAC: Feline Hyperthyroidism: Virbac acquires Thyronorm
16/12/2025
Acquisition provides Virbac with a leading specialty product, in a growing segment, to improve the quality of life for senior cats. We are delighted to announce the acquisition of an innovative drug from Norbrook to [...]
VIRBAC: Hyperthyroïdie féline : Virbac acquiert Thyronorm
16/12/2025
Cette acquisition apporte à Virbac un produit de spécialité de premier plan, sur un segment en croissance, pour améliorer la qualité de vie des chats âgés. Nous sommes ravis d'annoncer l'acquisition auprès de Norbrook d [...]
Nicox Completes NCX 470 New Drug Application Key Data Generation for Submission as Planned in H1 2026
16/12/2025
Press Release Nicox Completes NCX 470 New Drug Application Key Data Generation for Submission as Planned in H1 2026 All clinical trial and long-term stability data required for the preparation of the New Drug [...]
Nicox finalise la génération des données clés de demande d’autorisation de mise sur le marché de NCX 470 pour un dépôt maintenu au premier semestre 2026
16/12/2025
Communiqué de presse Nicox finalise la génération des données clés de demande d’autorisation de mise sur le marché de NCX 470 pour un dépôt maintenu au premier semestre 2026 Toutes les données d’ essais cliniques et de [...]
Acentra Health Named to Northern Virginia Technology Council’s Tech100
16/12/2025
Award honors Northern Virginia organizations for making a positive impact on the region’s technology community MCLEAN, Va., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Acentra Health , a technology and health solutions company [...]
Brain Based Health Solutions’ Dr. Clint Steele Releases “101 Brain Hacks” to Rewrite the Future of Dementia Prevention and Even Reversal
16/12/2025
Portland, Maine, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Most people believe dementia is a life sentence. Dr. Clint Steele once believed that, too, until a moment in his practice changed everything. Today, the #1 best-selling [...]
Fractyl Health Announces Call of Tranche A Warrants Tied to August 2025 Public Offering Following Achievement of Clinical and Trading Milestones
15/12/2025
Holders will have until December 30, 2025 to exercise Tranche A Warrants at $1.05 per share, enabling up to $17.9 million in potential gross proceeds BURLINGTON, Mass., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, [...]

Pages